Clarisse Lorin

1.3k total citations
20 papers, 775 citations indexed

About

Clarisse Lorin is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, Clarisse Lorin has authored 20 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Virology and 7 papers in Infectious Diseases. Recurrent topics in Clarisse Lorin's work include HIV Research and Treatment (9 papers), Virology and Viral Diseases (8 papers) and vaccines and immunoinformatics approaches (5 papers). Clarisse Lorin is often cited by papers focused on HIV Research and Treatment (9 papers), Virology and Viral Diseases (8 papers) and vaccines and immunoinformatics approaches (5 papers). Clarisse Lorin collaborates with scholars based in Belgium, France and United States. Clarisse Lorin's co-authors include Frédéric Tangy, Michel Brahic, Chantal Combredet, Frédéric Delebecque, Lucile Mollet, Bruno Hurtrel, Marie‐Pascale Frenkiel, Philippe Desprès, Valérie Labrousse and Pierre Charneau and has published in prestigious journals such as PLoS ONE, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Clarisse Lorin

20 papers receiving 745 citations

Peers

Clarisse Lorin
Lakshmi Jayashankar United States
Jérôme Salmon United States
Ken Lemon United Kingdom
Phil Felgner United States
Jay R. Radke United States
Kimberly B. Hummel United States
Clarisse Lorin
Citations per year, relative to Clarisse Lorin Clarisse Lorin (= 1×) peers Aurore Vidy

Countries citing papers authored by Clarisse Lorin

Since Specialization
Citations

This map shows the geographic impact of Clarisse Lorin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarisse Lorin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarisse Lorin more than expected).

Fields of papers citing papers by Clarisse Lorin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clarisse Lorin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarisse Lorin. The network helps show where Clarisse Lorin may publish in the future.

Co-authorship network of co-authors of Clarisse Lorin

This figure shows the co-authorship network connecting the top 25 collaborators of Clarisse Lorin. A scholar is included among the top collaborators of Clarisse Lorin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarisse Lorin. Clarisse Lorin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Warter, Lucile, et al.. (2023). Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models. npj Vaccines. 8(1). 143–143. 10 indexed citations
2.
McCracken, Michael K., Gregory D. Gromowski, Lindsey S. Garver, et al.. (2020). Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques. PLoS neglected tropical diseases. 14(4). e0008191–e0008191. 19 indexed citations
3.
Lorin, Clarisse, et al.. (2020). A new therapeutic candidate vaccine can overcome hepatitis B virus-induced immune tolerance in a mouse model of chronic infection. Journal of Hepatology. 73. S571–S571. 2 indexed citations
4.
Marchevsky, Renato Sérgio, Leonardo Diniz‐Mendes, Marcos S. Freire, et al.. (2019). Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines. PLoS Pathogens. 15(4). e1007721–e1007721. 23 indexed citations
5.
Marchevsky, Renato Sérgio, Ana María Bispo de Filippis, Pedro Fernando da Costa Vasconcelos, et al.. (2018). Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques. PLoS ONE. 13(4). e0196311–e0196311. 7 indexed citations
6.
Phillips, Bonnie, Koen K. A. Van Rompay, Clarisse Lorin, et al.. (2018). Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques. Journal of Virology. 92(20). 33 indexed citations
7.
Wang, Zihao, Clarisse Lorin, Marguerite Koutsoukos, et al.. (2016). Comprehensive Characterization of Reference Standard Lots of HIV-1 Subtype C Gp120 Proteins for Clinical Trials in Southern African Regions. Vaccines. 4(2). 17–17. 13 indexed citations
8.
Lorin, Clarisse, Yannick Vanloubbeeck, Marguerite Koutsoukos, et al.. (2015). Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques. PLoS ONE. 10(4). e0122835–e0122835. 9 indexed citations
9.
Bourguignon, Patricia, Frédéric Clément, Marguerite Koutsoukos, et al.. (2014). Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients. Journal of Immunological Methods. 414. 1–10. 17 indexed citations
10.
Boxus, Mathieu, et al.. (2014). Antibody avidity measurements in recipients of Cervarix® vaccine following a two-dose schedule or a three-dose schedule. Vaccine. 32(26). 3232–3236. 31 indexed citations
11.
Stebbings, Richard, Bo Li, Clarisse Lorin, et al.. (2013). Immunogenicity of a recombinant measles HIV-1 subtype C vaccine. Vaccine. 31(51). 6079–6086. 17 indexed citations
12.
Lorin, Clarisse, Lawrence Segal, Johann Mols, et al.. (2012). Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(12). 1211–1225. 18 indexed citations
13.
Stebbings, Richard, Michèle Février, Bo Li, et al.. (2012). Immunogenicity of a Recombinant Measles-HIV-1 Clade B Candidate Vaccine. PLoS ONE. 7(11). e50397–e50397. 32 indexed citations
14.
Tokuyama, Maria, Clarisse Lorin, Frédéric Delebecque, et al.. (2011). Expression of the RAE-1 Family of Stimulatory NK-Cell Ligands Requires Activation of the PI3K Pathway during Viral Infection and Transformation. PLoS Pathogens. 7(9). e1002265–e1002265. 45 indexed citations
15.
Lorin, Clarisse, Héla Saïdi, Afifa Belaïd, et al.. (2005). The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology. 334(2). 264–275. 126 indexed citations
16.
Lorin, Clarisse, Chantal Combredet, Valérie Labrousse, et al.. (2005). A Paediatric Vaccination Vector Based on Live Attenuated Measles Vaccine. Therapies. 60(3). 227–233. 7 indexed citations
17.
Lorin, Clarisse, Frédéric Delebecque, Valérie Labrousse, et al.. (2005). A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes. Vaccine. 23(36). 4463–4472. 34 indexed citations
18.
Desprès, Philippe, Chantal Combredet, Marie‐Pascale Frenkiel, et al.. (2004). Live Measles Vaccine Expressing the Secreted Form of the West Nile Virus Envelope Glycoprotein Protects against West Nile Virus Encephalitis. The Journal of Infectious Diseases. 191(2). 207–214. 111 indexed citations
20.
Combredet, Chantal, Valérie Labrousse, Lucile Mollet, et al.. (2003). A Molecularly Cloned Schwarz Strain of Measles Virus Vaccine Induces Strong Immune Responses in Macaques and Transgenic Mice. Journal of Virology. 77(21). 11546–11554. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026